# Azithromycin Combination Therapy for the Treatment of Severe Malaria

> **NCT01374126** · PHASE2 · COMPLETED · sponsor: **Medical University of Vienna** · enrollment: 75 (actual)

## Conditions studied

- Falciparum Malaria

## Interventions

- **DRUG:** Artesunate
- **DRUG:** Azithromycin + Artesunate

## Key facts

- **NCT ID:** NCT01374126
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2012-11
- **Final completion:** 2012-11
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2013-08-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01374126

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01374126, "Azithromycin Combination Therapy for the Treatment of Severe Malaria". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01374126. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*